These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
363 related items for PubMed ID: 19197004
1. Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil. Zolkowska D, Jain R, Rothman RB, Partilla JS, Roth BL, Setola V, Prisinzano TE, Baumann MH. J Pharmacol Exp Ther; 2009 May; 329(2):738-46. PubMed ID: 19197004 [Abstract] [Full Text] [Related]
2. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence. Baumann MH, Phillips JM, Ayestas MA, Ali SF, Rice KC, Rothman RB. Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088 [Abstract] [Full Text] [Related]
3. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats. Broom SL, Yamamoto BK. Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185 [Abstract] [Full Text] [Related]
4. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse. Loland CJ, Mereu M, Okunola OM, Cao J, Prisinzano TE, Mazier S, Kopajtic T, Shi L, Katz JL, Tanda G, Newman AH. Biol Psychiatry; 2012 Sep 01; 72(5):405-13. PubMed ID: 22537794 [Abstract] [Full Text] [Related]
5. The synthetic cathinones, butylone and pentylone, are stimulants that act as dopamine transporter blockers but 5-HT transporter substrates. Saha K, Li Y, Holy M, Lehner KR, Bukhari MO, Partilla JS, Sandtner W, Sitte HH, Baumann MH. Psychopharmacology (Berl); 2019 Mar 01; 236(3):953-962. PubMed ID: 30345459 [Abstract] [Full Text] [Related]
6. The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice. Mereu M, Chun LE, Prisinzano TE, Newman AH, Katz JL, Tanda G. Eur J Neurosci; 2017 Jan 01; 45(1):167-174. PubMed ID: 27545285 [Abstract] [Full Text] [Related]
7. Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin. Suyama JA, Sakloth F, Kolanos R, Glennon RA, Lazenka MF, Negus SS, Banks ML. J Pharmacol Exp Ther; 2016 Jan 01; 356(1):182-90. PubMed ID: 26645638 [Abstract] [Full Text] [Related]
8. Distinct dose-dependent effects of methamphetamine on real-time dopamine transmission in the rat nucleus accumbens and behaviors. Bhimani RV, Vik M, Wakabayashi KT, Szalkowski C, Bass CE, Park J. J Neurochem; 2021 Aug 01; 158(4):865-879. PubMed ID: 34265079 [Abstract] [Full Text] [Related]
9. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine. Bjorklund NL, Sorg BA, Schenk JO. Synapse; 2008 Oct 01; 62(10):736-45. PubMed ID: 18651643 [Abstract] [Full Text] [Related]
10. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal. Broderick PA, Hope O, Okonji C, Rahni DN, Zhou Y. Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan 01; 28(1):157-71. PubMed ID: 14687870 [Abstract] [Full Text] [Related]
11. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Shoblock JR, Sullivan EB, Maisonneuve IM, Glick SD. Psychopharmacology (Berl); 2003 Feb 01; 165(4):359-69. PubMed ID: 12491026 [Abstract] [Full Text] [Related]
12. Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats. Hersey M, Mereu M, Jones CS, Bartole MK, Chen AY, Cao J, Hiranita T, Chun LE, Lopez JP, Katz JL, Newman AH, Tanda G. Eur J Neurosci; 2024 May 01; 59(10):2436-2449. PubMed ID: 38444104 [Abstract] [Full Text] [Related]
13. Distinct effects of (R)-modafinil and its (R)- and (S)-fluoro-analogs on mesolimbic extracellular dopamine assessed by voltammetry and microdialysis in rats. Keighron JD, Giancola JB, Shaffer RJ, DeMarco EM, Coggiano MA, Slack RD, Newman AH, Tanda G. Eur J Neurosci; 2019 Aug 01; 50(3):2045-2053. PubMed ID: 30402972 [Abstract] [Full Text] [Related]
14. Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate. Baumann MH, Ayestas MA, Sharpe LG, Lewis DB, Rice KC, Rothman RB. J Pharmacol Exp Ther; 2002 Jun 01; 301(3):1190-7. PubMed ID: 12023554 [Abstract] [Full Text] [Related]
15. Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats. Tunstall BJ, Ho CP, Cao J, Vendruscolo JCM, Schmeichel BE, Slack RD, Tanda G, Gadiano AJ, Rais R, Slusher BS, Koob GF, Newman AH, Vendruscolo LF. Neuropharmacology; 2018 Mar 15; 131():96-103. PubMed ID: 29217282 [Abstract] [Full Text] [Related]
17. Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux. Desai RI, Paronis CA, Martin J, Desai R, Bergman J. J Pharmacol Exp Ther; 2010 Jun 15; 333(3):834-43. PubMed ID: 20190012 [Abstract] [Full Text] [Related]
18. Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents. Paterson NE, Fedolak A, Olivier B, Hanania T, Ghavami A, Caldarone B. Pharmacol Biochem Behav; 2010 Jun 15; 95(4):449-56. PubMed ID: 20346966 [Abstract] [Full Text] [Related]
19. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog-Torres K. JAMA; 2009 Mar 18; 301(11):1148-54. PubMed ID: 19293415 [Abstract] [Full Text] [Related]
20. Methamphetamine increases dopamine release in the nucleus accumbens through calcium-dependent processes. Yorgason JT, Hedges DM, Obray JD, Jang EY, Bills KB, Woodbury M, Williams B, Parsons MJ, Andres MA, Steffensen SC. Psychopharmacology (Berl); 2020 May 18; 237(5):1317-1330. PubMed ID: 31965252 [Abstract] [Full Text] [Related] Page: [Next] [New Search]